(Q35936874)

11 August 2017

1 reference

title

Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment (English)

1 reference

11 August 2017

0 references

Abhilash K Desai

1

1 reference

11 August 2017

George T Grossberg

series ordinal

2

1 reference

11 August 2017

Dharmesh N Sheth

series ordinal

3

1 reference

11 August 2017

language of work or name

1 reference

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

18

1 reference

11 August 2017

13

1 reference

11 August 2017

853-875

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200418130-00003

11 August 2017

0 references

cites work

Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale.

1 reference

12 December 2020

Functional disability in Alzheimer's disease.

1 reference

12 December 2020

Predictors of the placement of cognitively impaired residents on special care units

1 reference

12 December 2020

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

1 reference

12 December 2020

Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

1 reference

12 December 2020

The Bayer Activities of Daily Living Scale (B-ADL).

1 reference

12 December 2020

Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations

1 reference

12 December 2020

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

12 December 2020

Methodological issues in measuring the functional status of cognitively impaired nursing home residents: the use of proxies and performance-based measures.

1 reference

12 December 2020

Clinical trials in Alzheimer's disease. A report from the Medical Research Council Alzheimer's Disease Clinical Trials Committee

1 reference

12 December 2020

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

12 December 2020

Clinical global impressions in Alzheimer's clinical trials.

1 reference

12 December 2020

The Global Deterioration Scale for assessment of primary degenerative dementia

1 reference

12 December 2020

The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

1 reference

12 December 2020

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

12 December 2020

Scientific and clinical problems in indexes of functional disability

1 reference

12 December 2020

Metrifonate therapy in Alzheimer's disease: a pooled analysis of four randomized, double-blind, placebo-controlled trials.

1 reference

12 December 2020

Measurement of functional activities in older adults in the community.

1 reference

12 December 2020

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

1 reference

12 December 2020

Structured assessment of independent living skills: preliminary report of a performance measure of functional abilities in dementia

1 reference

12 December 2020

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

12 December 2020

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

12 December 2020

The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease.

1 reference

12 December 2020

Second International Pharmacoeconomic Conference on Alzheimer' s Disease.

1 reference

12 December 2020

Physical Performance Test and Activities of Daily Living scales in the assessment of health status in elderly people

1 reference

12 December 2020

Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden

1 reference

12 December 2020

Functional assessment of the elderly. A comparison of standard instruments with clinical judgment

1 reference

12 December 2020

A new scale for the assessment of functional status in Alzheimer's disease and related disorders.

1 reference

12 December 2020

Cognitive impairment and functional disability in the absence of psychiatric diagnosis.

1 reference

12 December 2020

Time until institutionalization and death in patients with dementia. Role of caregiver training and risk factors.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

1 reference

12 December 2020

Mild cognitive impairment: transition between aging and Alzheimer's disease.

1 reference

12 December 2020

Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers.

1 reference

12 December 2020

Measurement and prediction of functional capacity in Alzheimer's disease

1 reference

12 December 2020

Disability and cognitive impairment in the elderly

1 reference

12 December 2020

Undetected dementia in community-dwelling older people: the Canadian Study of Health and Aging

1 reference

12 December 2020

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

12 December 2020

Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease

1 reference

12 December 2020

Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of functional and quality of life scales

1 reference

12 December 2020

Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.

1 reference

12 December 2020

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

1 reference

12 December 2020

The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials

1 reference

12 December 2020

The Direct Assessment of Functional Abilities (DAFA): a comparison to an indirect measure of instrumental activities of daily living

1 reference

12 December 2020

Correspondence of the functional independence measure (FIM) self-care subscale with real-time observations of dementia patients' ADL performance in the home

1 reference

12 December 2020

Assessing patient dependence in Alzheimer's disease.

1 reference

12 December 2020

The Clinical Dementia Rating (CDR): current version and scoring rules

1 reference

12 December 2020

Promoting well-being and independence for people with dementia.

1 reference

12 December 2020

Relationships between impairment and physical disability as measured by the functional independence measure

1 reference

12 December 2020

The impact of dementia on the family

1 reference

12 December 2020

Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes

1 reference

12 December 2020

Longitudinal assessment of patient dependence in Alzheimer disease.

1 reference

12 December 2020

Interrater reliability of the Physical Self-Maintenance Scale and the Instrumental Activities of Daily Living Scale in a variety of health professional representatives.

1 reference

12 December 2020

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

1 reference

12 December 2020

On the paradox of improving sensitivity of ADL scales for the detection of behavioral changes in early dementia

1 reference

12 December 2020

Use of neuropsychological tests to predict adult patients' everyday functioning

1 reference

12 December 2020

FUNCTIONAL EVALUATION: THE BARTHEL INDEX

1 reference

12 December 2020

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

1 reference

12 December 2020

Measuring functioning in daily activities for persons with dementia.

1 reference

12 December 2020

Functional decline in Alzheimer's disease: a longitudinal study.

1 reference

12 December 2020

Aging, memory, and mild cognitive impairment.

1 reference

12 December 2020

The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease.

1 reference

12 December 2020

Risk factors for functional status decline in community-living elderly people: a systematic literature review

1 reference

12 December 2020

The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease

1 reference

12 December 2020

Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living

1 reference

12 December 2020

A correlation between cognitive performance and daily functioning in elderly people.

1 reference

12 December 2020

The Bayer-Activities of Daily Living Scale (B-ADL): results from a validation study in three European countries.

1 reference

12 December 2020

Combining activities of daily living with instrumental activities of daily living to measure functional disability.

1 reference

12 December 2020

The disablement process.

1 reference

12 December 2020

An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors

1 reference

12 December 2020

The disablement process: a conceptual framework for dementia-associated disability

1 reference

12 December 2020

Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration

1 reference

12 December 2020

Canadian guidelines for the development of antidementia therapies: a conceptual summary.

1 reference

12 December 2020

Diagnosing dementia: perspectives of primary care physicians.

1 reference

12 December 2020

AD2000: donepezil in Alzheimer's disease

1 reference

12 December 2020

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

12 December 2020

Memantine in moderate-to-severe Alzheimer's disease

1 reference

12 December 2020

Assessment of older people: self-maintaining and instrumental activities of daily living

1 reference

12 December 2020

The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons

1 reference

12 December 2020

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

12 December 2020

Dementia: characteristics of a referral population and factors associated with progression.

1 reference

12 December 2020

Correlates of disability among elderly retirees with "subclinical" cognitive impairment.

1 reference

12 December 2020

Progress in Development of the Index of ADL

1 reference

12 December 2020

Mental status as a predictor of daily function in progressive dementia

1 reference

12 December 2020

Predicting conversion to Alzheimer disease using standardized clinical information.

1 reference

12 December 2020

A new clinical scale for the staging of dementia.

1 reference

12 December 2020

Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease.

1 reference

12 December 2020

Assessing functioning and self-care abilities in Alzheimer disease research

1 reference

12 December 2020

Executive cognitive impairment: a novel perspective on dementia

1 reference

12 December 2020

Measurement of quality-of-life changes in patients with Alzheimer's disease.

1 reference

12 December 2020

Functional decline in older adults: expanding methods of ascertainment

1 reference

12 December 2020

Formal education as an effect modifier of the relationship between Mini-Mental State Examination score and IADLs disability in the older population.

1 reference

12 December 2020

Documentation and evaluation of cognitive impairment in elderly primary care patients.

1 reference

12 December 2020

Development and validation of the geriatric evaluation by relatives rating instrument (GERRI).

1 reference

12 December 2020

Assessing the severity of dementia. Patient and caregiver

1 reference

12 December 2020

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

12 December 2020

The perspective of the patient with Alzheimer's disease: a neglected dimension of dementia research.

1 reference

12 December 2020

Outcome measures for the study of activities of daily living in vascular dementia

1 reference

12 December 2020

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

12 December 2020

Systematic biases in functional status assessment of elderly adults: effects of different data sources.

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes

1 reference

12 December 2020

Comparing motor and process ability of persons with suspected dementia in home and clinic settings

1 reference

12 December 2020

Development of the refined ADL Assessment Scale for patients with Alzheimer's and related disorders

1 reference

12 December 2020

Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis

1 reference

12 December 2020

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

1 reference

12 December 2020

Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality.

1 reference

12 December 2020

The Alzheimer's disease activities of daily living international scale (ADL-IS).

1 reference

12 December 2020

10.2165/00023210-200418130-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference